Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-10

Clinical Trial Update: Tryptophan for Impaired AhR Signaling in Celiac Disease [NA]

View source ↗

Summary

A clinical trial sponsored by McMaster University is evaluating tryptophan to address impaired aryl hydrocarbon receptor signaling in celiac disease. The study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • L-tryptophan (L-tryptophan)

Snippet

Sponsor: McMaster University | Conditions: Tryptophan Metabolism Alterations, Celiac Disease | NA | Status: RECRUITING